← Browse by Condition
Medical Condition

renal cell carcinoma

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 1, Phase 2, Phase 2, Phase 3
NCT06047379 Phase 1, Phase 2
Recruiting

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Enrollment
134 pts
Location
United States
Sponsor
Neonc Technologies, Inc.
View Trial →
NCT06424080
Recruiting

Oncological and Perioperative Outcomes of Laparoscopic Versus Robotic Partial Nephrectomy for Treatment of Renal Tumors.

Enrollment
20 pts
Location
Egypt
Sponsor
Menoufia University
View Trial →
NCT07301827
Recruiting

Study on the Diagnostic Value of Novel PET Molecular Imaging for Renal Cell Carcinoma

Enrollment
66 pts
Location
China
Sponsor
Union Hospital, Tongji Medical...
View Trial →
NCT04006522 Phase 2
Recruiting

89Zr-DFO-Atezolizumab ImmunoPET/CT in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma

Enrollment
55 pts
Location
United States
Sponsor
James Brugarolas
View Trial →
NCT03288532 Phase 3
Recruiting

Renal Adjuvant MultiPle Arm Randomised Trial

Enrollment
1,750 pts
Location
United Kingdom
Sponsor
University College, London
View Trial →